Delay in NHS patients' access to cancer drug labelled a 'disgrace'
Thursday, 6 August 2015
The GuardianDelay in NHS patients' access to cancer drug labelled a 'disgrace'The GuardianA delay in access to a drug that has been shown to double the life expectancy of some patients with lung cancer has been described as a “disgrace”. Paula Chadwick, chief executive of Roy Castle Lung Cancer Foundation, said patients are unlikely to be ...Lung cancer patients often experience delays before surgeryHouston Chronicle (subscription)all 7 news articles »